Results 81 to 90 of about 213,956 (190)
ResumenEl cáncer gástrico (CG) mantiene alta prevalencia en Chile, con una tasa de mortalidad de 20/100.000 habitantes. Se reconocen dos variantes histológicas, el tipo difuso y el tipo intestinal.
Enrique Norero, M., Sergio Guzmán, B.
core +2 more sources
In this explorative biomarker analysis, we assessed serial sampling of circulating tumor cells (CTCs) with CellSearch in two randomized trials testing immune checkpoint inhibitors (ICIs) in metastatic breast cancer. Our data demonstrate a prognostic potential of CTCs, most apparent 4 weeks into ICI therapy.
Nikolai Kragøe Andresen+13 more
wiley +1 more source
Con este libro, los autores, presentan los niveles técnicos y científicos alcanzados por la medicina especializada, en el diagnóstico y tratamiento de esta enfermedad tan antigua como el ...
De la Garza Salazar, Jaime G.+1 more
core
Circulating tumor cells: advancing personalized therapy in small cell lung cancer patients
Small cell lung cancer (SCLC) is an aggressive form of lung cancer that spreads rapidly to secondary sites such as the brain and liver. Cancer cells circulating in the blood, “circulating tumor cells” (CTCs), have demonstrated prognostic value in SCLC, and evaluating biomarkers on CTCs could guide treatment decisions such as for PARP inhibitors ...
Prajwol Shrestha+6 more
wiley +1 more source
Mecanismo de acción de la putrescina sobre la proliferación de células endoteliales de colon [PDF]
El cáncer de colon o cáncer colorrectal (CRC) es una de las principales causas de muerte en nuestro país y en el mundo, siendo uno de los canceres más comunes.
Prieto Peñín, Águeda
core
Causal attribution to cervical cancer [PDF]
This study aimed to examine the causal attribution for cervical cancer for women with and without the disease. Seventy-eight (78) users from the public healthcare system participated, which were divided into: a clinical group (CG) of women with cervical ...
Armiliato, María Julia+3 more
core +2 more sources
A comparative study of circulating tumor cell isolation and enumeration technologies in lung cancer
Lung cancer cells were spiked into donor blood to evaluate the recovery rates of the following circulating tumor cell (CTC) enrichment technologies: CellMag™, EasySep™, RosetteSep™, Parsortix® PR1, and Parsortix® Prototype systems. Each method's advantages and disadvantages are described.
Volga M Saini+11 more
wiley +1 more source
Cell‐free and extracellular vesicle microRNAs with clinical utility for solid tumors
Cell‐free microRNAs (cfmiRs) are small‐RNA circulating molecules detectable in almost all body biofluids. Innovative technologies have improved the application of cfmiRs to oncology, with a focus on clinical needs for different solid tumors, but with emphasis on diagnosis, prognosis, cancer recurrence, as well as treatment monitoring.
Yoshinori Hayashi+6 more
wiley +1 more source
Factores pronósticos del cáncer de seno: Hospital Militar Central periodo enero 2003 - diciembre 2008 [PDF]
El cáncer de Seno representa el diagnóstico más frecuente de cáncer en las mujeres y la segunda causa de muerte por esta enfermedad a nivel mundial. El riesgo de desarrollarlo durante la vida es del 13,4% (1 de cada 7 mujeres) y la posibilidad de morir ...
Cantor Rizo, Erick Andrés+1 more
core
This study demonstrates that KRAS and GNAS mutations are more prevalent in patients with resected intraductal papillary mucinous neoplasms (IPMN) compared to those under clinical surveillance. GNAS mutations significantly differ between the two patient cohorts, indicating that their absence may serve as a potential biomarker to support conservative ...
Christine Nitschke+12 more
wiley +1 more source